Trade Summary

6 days ago, Lynx1 Capital Management LP, serving as 10% owner Owner at Passage BIO, Inc. (PASG), purchased 50,055 shares at $4.12 per share, for a total transaction value of $206,101.46. Following this transaction, Lynx1 Capital Management LP now holds 673,759 shares of PASG.

This purchase represents a 8.03% increase in Lynx1 Capital Management LP's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 25, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 29, 2026 at 4:30 PM ET, 4 days after the trade was made.

Passage BIO, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.